Corporate Development

We will continue to build our leading acute and intensive care medicine business globally by selectively investing in, partnering, licensing or acquiring innovative drug products, medical devices and diagnostic solutions. Our primary focus is on opportunities that offer a strategic fit in acute and critical care medicine, that leverage our current business infrastructure and that provide differentiated benefits to our customers. We seek innovative solutions that advance the economic performance of healthcare across the globe, provide solutions that allow for innovation in how healthcare is delivered, and most importantly, offer the highest level of care to our patients.